ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
-7.16%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(-18%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-8.85%
Top 10 Holdings %
Top 10 Hldgs %
28.97%
Holding
146
New
25
Increased
17
Reduced
13
Closed
22
Top Buys
| 1 |
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
|
$7.25M |
| 2 |
STAAR Surgical
STAA
|
$5.32M |
| 3 |
Guardant Health
GH
|
$4.24M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$3.97M |
| 5 |
AKYA
Akoya BioSciences
AKYA
|
$3.8M |
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
$9.14M |
| 2 |
Esperion Therapeutics
ESPR
|
$8.48M |
| 3 |
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
|
$7.23M |
| 4 |
Globus Medical
GMED
|
$5.83M |
| 5 |
Tandem Diabetes Care
TNDM
|
$5.82M |
Sector Composition
| 1 | Healthcare | 77.73% |
| 2 | Financials | 12.35% |
| 3 | Industrials | 1.35% |
| 4 | Technology | 1.05% |
| 5 | Consumer Discretionary | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $10.8M | 4.3% | 615,000 +70,000 | +13% | +$1.22M |
|
|
BLU
2
DELISTED
BELLUS Health Inc.
BLU
| $8.43M | 3.37% | 912,000 -538,006 | -37% | -$4.97M |
|
3
ADMA Biologics
ADMA
$4.12B
| $7.92M | 3.17% | 4,000,000 +700,000 | +21% | +$1.39M |
|
|
4
Esperion Therapeutics
ESPR
$448M
| $7.4M | 2.96% | 1,162,869 -1,333,655 | -53% | -$8.48M |
|
|
PEPL
5
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $7.25M | 2.9% | +735,000 | New | +$7.25M |
|
6
Lantheus
LNTH
$3.73B
| $5.81M | 2.33% | 88,000 +48,000 | +120% | +$3.17M |
|
|
7
STAAR Surgical
STAA
$1.36B
| $5.32M | 2.13% | +75,000 | New | +$5.32M |
|
8
Insmed
INSM
$28.8B
| $5.29M | 2.11% | 268,000 | – | – |
|
9
Glaukos
GKOS
$5.5B
| $5.18M | 2.07% | 114,000 +20,000 | +21% | +$908K |
|
|
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
| $5.16M | 2.07% | 1,750,000 | – | – |
|
|
MBTC
11
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
| $5.1M | 2.04% | 500,000 | – | – |
|
12
QuidelOrtho
QDEL
$1.95B
| $4.86M | 1.94% | 50,000 -6,000 | -11% | -$583K |
|
13
Inspire Medical Systems
INSP
$2.77B
| $4.38M | 1.75% | 24,000 +8,000 | +50% | +$1.46M |
|
|
ITCI
14
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.28M | 1.71% | 75,000 +52,500 | +233% | +$3M |
|
|
15
Guardant Health
GH
$8.41B
| $4.24M | 1.7% | +105,000 | New | +$4.24M |
|
16
Myriad Genetics
MYGN
$593M
| $4.02M | 1.61% | 221,000 +106,290 | +93% | +$1.93M |
|
|
CCXI
17
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.97M | 1.59% | +160,000 | New | +$3.97M |
|
|
EUCR
18
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $3.96M | 1.58% | 400,000 | – | – |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $3.9M | 1.56% | 89,000 +12,000 | +16% | +$526K |
|
|
AKYA
20
DELISTED
Akoya BioSciences
AKYA
| $3.8M | 1.52% | +296,000 | New | +$3.8M |
|
21
Inogen
INGN
$216M
| $3.77M | 1.51% | +156,000 | New | +$3.77M |
|
22
Trevi Therapeutics
TRVI
$883M
| $3.61M | 1.44% | +1,284,000 | New | +$3.61M |
|
23
Verastem
VSTM
$569M
| $3.48M | 1.39% | 3,000,000 +49,000 | +2% | +$56.8K |
|
24
DexCom
DXCM
$29.5B
| $3.28M | 1.31% | 44,000 +31,500 | +252% | +$2.35M |
|
25
Xtant Medical Holdings
XTNT
$83.3M
| $3.25M | 1.3% | 6,246,291 | – | – |
|